Navigation Links
New Snoring Therapy Awarded The Prestigious Spark Award

SAN JOSE, Calif., Nov. 8, 2012 /PRNewswire/ -- Ventus Medical announces that their Theravent Advanced Nightly Snore Therapy has received the prestigious Spark Award.  Theravent won silver in the 2012 Spark competition for Product Design. The Spark Awards reward innovative design that helps humanity or the environment we live in. The mission of the award is to promote better living through better design. 



"The Theravent product is already helping a lot of couples get a better night's sleep," says Peter Wyles, CEO and President of Ventus Medical.  "Ventus worked with LUNAR on developing the very innovative Theravent product and we were able to create an elegant design that gives people an easy to use solution to effectively treat their snoring.  This is an important accomplishment in a market where 45 million people snore and their bed partners suffer."

"We are thrilled to see Theravent win this recognition," said John Edson, LUNAR's president.  "This simple, ingenious product is the most recent result of a lot of hard work and an amazing collaboration between the teams at Ventus and LUNAR. Even more satisfying than the award is seeing these products help a lot of people."

Theravent is a unique, disposable nightly snoring device that is FDA-cleared to reduce or eliminate snoring.  It has been proven to reduce snoring in clinical studies and is available without a prescription.  On average, successful Theravent users reduced snoring by 76%, as measured using a decibel meter worn on the forehead. Theravent uses the same patented MicroValve Technology that was previously only available with a prescription.  It is available exclusively on-line at

About Theravent Advanced Nightly Snore Therapy
Theravent is a new, clinically proven, over-the-counter treatment for snoring. Theravent offers a proven solution for patients whose snoring is affecting the quality of their and their partners' sleep. Used nightly, Theravent gives snorers and their partners a quiet night's sleep. Theravent uses patented MicroValve Technology, previously only available with a prescription, to target and treat snoring. During inhalation, the MicroValves open--allowing nearly unobstructed airflow.  During exhalation, the MicroValves partially close, which increases expiratory pressure and keeps the airway open, preventing snoring.  Theravent received FDA clearance in June 2012. Theravent is not intended to treat obstructive sleep apnea.  For more information, please visit

About Provent® Sleep Apnea Therapy
Provent Sleep Apnea Therapy is a proprietary medical device for the treatment of obstructive sleep apnea (OSA).  The device has proven to be clinically effective in a series of published studies.  It is an easy to use, non-invasive disposable treatment that works across mild, moderate and severe OSA. Provent Sleep Apnea Therapy utilizes nasal expiratory positive airway pressure (EPAP) to keep a patient's airway open during sleep.  It incorporates a novel MicroValve design that is placed over the nostrils and secured with hypoallergenic adhesive.  During inhalation, the valve opens allowing nearly unobstructed airflow.  During exhalation, the valve closes, limiting airflow through small openings, which increases expiratory pressure and keeps the airway open, preventing disruption in breathing.  Provent Sleep Apnea Therapy is FDA cleared, has CE marking and has been accepted onto the Australian Register of Therapeutic Goods (ARTG).  For more information, please visit

About Ventus Medical
Ventus Medical is a privately-held medical device company dedicated to providing non-invasive medical solutions for people with sleep disordered breathing. Based on its innovative MicroValve technology and patented designs, Ventus has developed a unique line of clinically-proven medical devices to address the continuum of sleep disorders from severe obstructive sleep apnea (OSA) to mild snoring. Ventus Medical's devices work by creating expiratory positive airway pressure (EPAP). The company markets Provent Sleep Apnea Therapy, a discreet, easy-to-use nasal device, for the treatment of obstructive sleep apnea and Theravent Snore Therapy an over-the-counter device for the treatment of snoring in the US.  Provent Sleep Apnea Therapy is also available in Australia, New Zealand, Hong Kong and Canada.

LUNAR uses emotional creativity to generate innovative products that make positive differences to people lives and that fuel outstanding results in businesses.  Founded in 1984, LUNAR's portfolio of highly successful products has consistently placed the company among the top award-winning product design and development firms globally, throughout its 28-year history.  LUNAR provides creative and technical product strategy, innovation, design and development to clients including Abbott, Apple, Cisco Systems, Hewlett-Packard, Johnson & Johnson, Microsoft, Motorola, Philips, Oral-B, Pepsi and Sony.  They have offices in California, Chicago, Europe and Hong Kong. For more information, visit  

SOURCE Ventus Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Improved Device Programming Reduces Inappropriate Therapy and Risk of Death for Implantable Defibrillator Patients
2. Novel Apolipoprotein A-I Therapy, CSL112, May Represent New Option for Reducing Recurrent Heart Attack Risk, Early CSL Studies Show
3. Dynamic Healthcare Services Acquires Evanko Respiratory Inc., a Provider of Medical Equipment and Respiratory Therapy Products and Services in Hazleton, PA
4. Radiation Therapy Alliance Commends CMS for Mitigating Drastic Cuts to Radiation Oncology
5. American Board of Radiology Foundation receives grant from Varian Medical Systems for national brachytherapy registry
6. West Health Institute licenses Kinect-based physical therapy technology to Reflexion Health; West Health Investment Fund makes $4.25 million investment
7. Oncology Systems Limited UK Renews Research and Collaboration Agreement with University Hospital Birmingham NHS Foundation Trust (UHB) - Radiotherapy Department
8. Elekta Introduces MOSAIQ Connectivity for its microSelectron Digital Brachytherapy Afterloader at ASTRO Annual Meeting
9. ViaCyte Receives $10.1 Million Strategic Partnership Award from CIRM to Continue Development of Diabetes Therapy
10. Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be operated by Emory Healthcare
11. Dynatronics Introduces New SolarisPlus Line of Therapy Products
Post Your Comments:
(Date:11/30/2015)... REHOVOT, Israel , Nov. 30, 2015 ... focused on acquiring and developing innovative therapies for ear, ... of Keith A. Katkin as chairman of ... Flesher , chief executive officer for OticPharma, Ltd.  "Keith ... As chairman, he will be able to share this ...
(Date:11/29/2015)...  Strengthening its leadership in connected healthcare informatics, ... IntelliSpace Portal 8.0 , the latest edition of ... helps radiologists detect, diagnose and follow-up on treatment of ... North America Annual Meeting (RSNA) in ... the changing demands in radiology that result from an ...
(Date:11/29/2015)... GE Health Cloud 1 was unveiled today at the ... America (RSNA) meeting in Chicago ... ecosystem and its applications will connect radiologists and clinicians to ... – both inside and outside the hospital setting. ... the digital industrial leader, we are betting big on the ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... Newly reviewed and approved “NJ ... graduated from Tufts School of Dental Medicine in 1935. His father graduated from ... family being in dentistry as well as their commitment and passion to the Practice ...
(Date:11/30/2015)... ... November 30, 2015 , ... The ... National Poison Data System (NPDS) reveals that in 2014, someone called a poison ... over two million of which were human exposure cases. , The American Association ...
(Date:11/30/2015)... ... , ... Two years ago, Debbie Gregory, the CEO of, found herself ... Meditation (TM). After encouraging a number of veterans to go through the program, ... the talk. , TM is becoming one of the best alternative treatments for Post-Traumatic ...
(Date:11/30/2015)... ... ... The American Society for Clinical Pathology (ASCP) announced today that it has launched ... ASCP shared its “Give a minute. Get tested. Find a cure.” icon and infographic ... tested for HIV. , ASCP has asked members to replace their Facebook, Twitter, or ...
(Date:11/30/2015)... Beach, FL (PRWEB) , ... November 30, 2015 ... ... of Consumer Reports magazine, quoted Michael Hansen, Ph.D., a senior scientist at Consumer ... and even more so for a child’s exposure limits. , The original Nov ...
Breaking Medicine News(10 mins):